Ignite Creation Date:
2024-05-05 @ 12:05 PM
Last Modification Date:
2024-10-26 @ 9:20 AM
Study NCT ID:
NCT00234390
Status:
COMPLETED
Last Update Posted:
2011-01-24
First Post:
2005-10-05
Brief Title:
PreAsthmaControl PAC
Sponsor:
AstraZeneca
Organization:
AstraZeneca
Study Overview
Official Title:
Prevention of Asthma in InfantsYoung Children - PAC
Status:
COMPLETED
Status Verified Date:
2011-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to investigate the ability of budesonide given during episodes of troublesome lung symptoms to reduce further symptoms in infants and young children at risk of developing asthma
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None